SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-000084
Filing Date
2024-01-02
Accepted
2024-01-02 07:05:31
Documents
12
Period of Report
2023-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm241304d1_8k.htm   iXBRL 8-K 56488
  Complete submission text file 0001104659-24-000084.txt   237600

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vygr-20231228.xsd EX-101.SCH 3048
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20231228_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20231228_pre.xml EX-101.PRE 22381
6 EXTRACTED XBRL INSTANCE DOCUMENT tm241304d1_8k_htm.xml XML 3206
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 24500193
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)